↓ Skip to main content

Cochrane Database of Systematic Reviews

Megestrol acetate for treatment of anorexia-cachexia syndrome

Overview of attention for article published in Cochrane database of systematic reviews, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
1 blog
twitter
12 tweeters
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
173 Dimensions

Readers on

mendeley
368 Mendeley
citeulike
1 CiteULike
Title
Megestrol acetate for treatment of anorexia-cachexia syndrome
Published in
Cochrane database of systematic reviews, March 2013
DOI 10.1002/14651858.cd004310.pub3
Pubmed ID
Authors

Vicente Ruiz Garcia, Eduardo López-Briz, Rafael Carbonell Sanchis, Jose Luis Gonzalvez Perales, Sylvia Bort-Martí

Abstract

This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia-cachexia syndrome'. Megestrol acetate (MA) is currently used to improve appetite and to increase weight in cancer-associated anorexia. In 1993, MA was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia or unexplained weight loss in patients with AIDS. The mechanism by which MA increases appetite is unknown and its effectiveness for anorexia and cachexia in neoplastic and AIDS (acquired immunodeficiency syndrome) patients is under investigation.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 368 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 2 <1%
Spain 2 <1%
United Kingdom 2 <1%
Switzerland 1 <1%
Hong Kong 1 <1%
Canada 1 <1%
Ireland 1 <1%
United States 1 <1%
Unknown 357 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 62 17%
Student > Postgraduate 39 11%
Student > Bachelor 38 10%
Researcher 38 10%
Student > Ph. D. Student 37 10%
Other 89 24%
Unknown 65 18%
Readers by discipline Count As %
Medicine and Dentistry 148 40%
Nursing and Health Professions 44 12%
Biochemistry, Genetics and Molecular Biology 19 5%
Agricultural and Biological Sciences 14 4%
Psychology 14 4%
Other 48 13%
Unknown 81 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2021.
All research outputs
#1,348,264
of 18,905,383 outputs
Outputs from Cochrane database of systematic reviews
#3,347
of 11,887 outputs
Outputs of similar age
#12,160
of 168,721 outputs
Outputs of similar age from Cochrane database of systematic reviews
#20
of 108 outputs
Altmetric has tracked 18,905,383 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,887 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.7. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,721 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.